P126 Pathological complete response after neoadjuvant chemotherapy in patients with HER2 low and HER2 0 early breast cancer (eBC) – experience from Institute for Oncology and Radiology of Serbia (IORS)

oleh: O. Djurmez, M. Calamac, N. Stanic, M. Dimitrijevic, J. Vukosavljevic, K. Serovic, J. Oblakovic-Babic, I. Minic, D. Gavrilovic, I. Bozovic-Spasojevic

Format: Article
Diterbitkan: Elsevier 2023-03-01

Deskripsi

No description available for this item.